Stillbirth Prevention Navigator
Evidence-based strategies by risk profile

Stillbirth Prevention Navigator

Match a pregnancy's risk profile to the prevention strategies that actually have published evidence โ€” with every number traceable to its source.

Evidence base

The publications this tool is built on. Every figure shown anywhere in the navigator traces to one of these sources.

PUBLICATIONS USED IN THIS TOOL
1
Silver RM, Reddy UM. Prevention of Stillbirth. Clin Perinatol. 2026;53(1):135โ€“147.
Anchor ยท Prevention Framework
Provides the prevention architecture: placental insufficiency as leading cause (up to 40%), risk stratification limits, and graded intervention evidence (aspirin, induction, DFM, bundles).
2
Widdows K, Roberts SA, Camacho EM, Heazell AEP. Stillbirth rates, service outcomes and costs of implementing NHS England's Saving Babies' Lives care bundle in maternity units in England: a cohort study. PLoS One. 2021;16(4):e0250150.
Cohort ยท Bundle Outcomes & Cost
>463,000 births. Stillbirth 4.2โ†’3.4/1000 (aRR 0.80) with parallel rises in induction, cesarean, scans and SGA detection. Source of the "intervention has trade-offs" data.
3
Andrews CJ, Ellwood D, Middleton PF, et al. Implementation and evaluation of a quality improvement initiative to reduce late gestation stillbirths in Australia: Safer Baby Bundle study protocol. BMC Pregnancy Childbirth. 2020;20:694.
Bundle ยท 5 Elements
Defines the 5 Safer Baby Bundle elements (smoking, FGR, DFM, safe sleep position, timing of birth) and the late-gestation reduction target (2.4โ†’1.9/1000).
4
Management of stillbirth. ACOG Obstetric Care Consensus No. 10. Obstet Gynecol. 2020;135:e110โ€“132.
Guideline ยท Risk Factors & Recurrence
Source of condition-specific stillbirth rates, recurrence risk (OR 4.83), and the subsequent-pregnancy surveillance protocol.
๐Ÿ”ฌ Primary trials cited within the anchor review

Key intervention figures in this tool originate in these primaries (cited within source โ‘ ) and were independently verified against PubMed / the original reports.

  • Hoffman MK, et al. Low-dose aspirin for the prevention of preterm delivery in nulliparous women with a singleton pregnancy (ASPIRIN): a randomised, double-blind, placebo-controlled trial. Lancet. 2020;395(10220):285โ€“293. โ€” perinatal mortality 45.7 vs 53.6/1,000; RR 0.86 (0.73โ€“1.00).
  • Po' G, Oliver EA, Reddy UM, Silver RM, Berghella V. The impact of induction of labor at 39 weeks in low-risk women on the incidence of stillbirth. Am J Obstet Gynecol. 2020;222(1):88โ€“90. โ€” ~883 US stillbirths/yr preventable; NNT โ‰ˆ1,675 inductions.

Step 1 โ€” Maternal & medical factors

Select all that apply. Estimated stillbirth rates shown are from ACOG Consensus No. 10 (per 1,000 births) and serve only to rank surveillance priority โ€” they are not additive.

Maternal medical conditions
Demographic / constitutional

Step 2 โ€” Current pregnancy & fetal factors

These factors most often act through placental insufficiency โ€” the leading cause of stillbirth in high-resource settings, up to 40% of cases (Silver & Reddy 2026).

Placental / fetal
Pregnancy characteristics

Step 3 โ€” History & modifiable factors

Modifiable factors are where prevention has the strongest, simplest evidence. Prior obstetric history drives subsequent-pregnancy surveillance.

Obstetric history
Modifiable behaviors

Step 4 โ€” Evidence-based prevention strategy

Strategies relevant to the selected profile, grouped by strength of evidence. Every figure cites its source.

๐Ÿ“‹ Stillbirth prevention bundles โ€” the population-level evidence

Several countries package these strategies into "bundles." They are associated with reduced stillbirth, but โ€” importantly โ€” efficacy of the bundle as a whole has not been definitively proven, and implementation carries trade-offs.

๐Ÿ“Š Reference: estimated stillbirth rates by condition

ACOG Obstetric Care Consensus No. 10, Table 1. Rate per 1,000 live births + stillbirths. Rows matching this profile are highlighted.

ConditionEst. rate /1,000
Sources: Silver & Reddy. Clin Perinatol 2026;53:135โ€“147 | Widdows et al. PLoS One 2021;16:e0250150 | Andrews et al. BMC Pregnancy Childbirth 2020;20:694 | ACOG Consensus No. 10. Obstet Gynecol 2020;135:e110โ€“132
Clinical decision support tool. Organizes published evidence; does not compute individual risk and does not replace clinical judgment. ยฉ 2026 LiveEvidence.com